|
2 Companies |
|
1 Product |
|
1 Product |
|
6 Mechanisms of Action |
|
0 Trials |
|
33 News |
|
- | Trial completion, Trial primary completion date: A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis (clinicaltrials.gov) - Apr 15, 2016
P2, N=40, Completed, Sponsor: Yung Shin Pharm. Ind. Co., Ltd.
Recruiting --> Completed | Trial primary completion date: Jul 2016 --> Dec 2015
- Trial completion, Trial primary completion date: Squarex: Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis (clinicaltrials.gov) - Sep 17, 2015
P1, N=60, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | Trial primary completion date: Jul 2016 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Sep 2015
- |||| Trial completion: Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores (clinicaltrials.gov) - Apr 10, 2015
P2, N=469, Completed, Sponsor: Topical Remedy
Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Sep 2015 Active, not recruiting --> Completed
- |||| thimerosal (BTL-TML) / Beech Tree Labs
Trial completion, Enrollment change: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Mar 5, 2015
P2, N=305, Completed, Sponsor: Beech Tree Labs, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=250 --> 305
- ||| thimerosal (BTL-TML) / Beech Tree Labs
Enrollment closed: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Sep 28, 2014
P2, N=250, Active, not recruiting, Sponsor: Beech Tree Labs, Inc.
Active, not recruiting --> Completed | N=250 --> 305 Recruiting --> Active, not recruiting
- || thimerosal (BTL-TML) / Beech Tree Labs
Trial primary completion date: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Aug 21, 2014
P2, N=250, Recruiting, Sponsor: Beech Tree Labs, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2014 --> Oct 2014
- | New P2 trial: A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis (clinicaltrials.gov) - Aug 4, 2014
P2, N=40, Recruiting, Sponsor: Yung Shin Pharm. Ind. Co., Ltd.
- | acyclovir / Generic mfg.
Phase classification: An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode (clinicaltrials.gov) - Jul 16, 2014
P1, N=60, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Jun 2014 --> Oct 2014 Phase classification: P2 --> P1
- Clinical: Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product. (clinicaltrials.gov) - Jun 3, 2014
P=N/A, N=0, Completed, Sponsor: Technische Universität Dresden
- ||||||| famciclovir / Generic mfg.
Trial completion: Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection (clinicaltrials.gov) - Feb 22, 2014
P3, N=74, Completed, Sponsor: Novartis Pharmaceuticals
Phase classification: P2 --> P1 Recruiting --> Completed
- ||| Enrollment closed: Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores (clinicaltrials.gov) - Jan 30, 2014
P2, N=480, Active, not recruiting, Sponsor: Topical Remedy
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Enrollment change: Zinc for the Treatment of Herpes Simplex Labialis (HSL) (clinicaltrials.gov) - Nov 18, 2013
P3, N=157, Completed, Sponsor: Integrative Medicine Institute
Recruiting --> Active, not recruiting N=106 --> 157
- | Trial completion: Zinc for the Treatment of Herpes Simplex Labialis (HSL) (clinicaltrials.gov) - Nov 18, 2013
P3, N=157, Completed, Sponsor: Integrative Medicine Institute
N=106 --> 157 Recruiting --> Completed
- ||||| New P2 trial: Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores (clinicaltrials.gov) - Nov 13, 2013
P2, N=480, Active, not recruiting, Sponsor: Topical Remedy
- Enrollment open: Squarex: Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis (clinicaltrials.gov) - Oct 28, 2013
P1, N=60, Recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting
- New P1 trial: Squarex: Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis (clinicaltrials.gov) - Oct 27, 2013
P1, N=60, Recruiting, Sponsor: Massachusetts General Hospital
- |||| thimerosal (BTL-TML) / Beech Tree Labs
Enrollment open: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Jul 17, 2013
P2, N=250, Recruiting, Sponsor: Beech Tree Labs, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| thimerosal (BTL-TML) / Beech Tree Labs
New P2 trial: Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores (clinicaltrials.gov) - Jul 16, 2013
P2, N=250, Recruiting, Sponsor: Beech Tree Labs, Inc.
- |||| thimerosal (BTL-TML) / Beech Tree Labs
Trial completion: Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection (clinicaltrials.gov) - Mar 4, 2013
P1/2, N=171, Completed, Sponsor: Beech Tree Labs, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| acyclovir / Generic mfg.
Trial initiation date, Head-to-Head: Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis (clinicaltrials.gov) - Feb 28, 2013
P3, N=76, Completed, Sponsor: EMS
Active, not recruiting --> Completed Initiation date: Jun 2011 --> Feb 2012
- ||||||| acyclovir / Generic mfg.
Trial completion, Head-to-Head: Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis (clinicaltrials.gov) - Feb 28, 2013
P3, N=76, Completed, Sponsor: EMS
Initiation date: Jun 2011 --> Feb 2012 Not yet recruiting --> Completed
- ||||| acyclovir / Generic mfg.
Enrollment change: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old (clinicaltrials.gov) - Feb 14, 2013
P3, N=51, Completed, Sponsor: Meda Pharmaceuticals
Not yet recruiting --> Completed N=186 --> 51
- ||||||| acyclovir / Generic mfg.
Trial completion: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old (clinicaltrials.gov) - Feb 14, 2013
P3, N=51, Completed, Sponsor: Meda Pharmaceuticals
N=186 --> 51 Recruiting --> Completed
- |||| acyclovir / Generic mfg.
Trial completion: An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode (clinicaltrials.gov) - Nov 27, 2012
P2, N=60, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Not yet recruiting --> Completed
- ||||| acyclovir / Generic mfg.
New P2 trial: An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode (clinicaltrials.gov) - Jul 29, 2012
P2, N=60, Completed, Sponsor: GlaxoSmithKline
- |||||||||| acyclovir / Generic mfg.
New P3 trial: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old (clinicaltrials.gov) - Apr 8, 2012
P3, N=51, Completed, Sponsor: Meda Pharmaceuticals
- Trial completion: Study of a Cold Sore Patch for the Treatment of Herpes Labialis (clinicaltrials.gov) - Apr 1, 2012
P=N/A, N=472, Completed, Sponsor: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
Not yet recruiting --> Completed Active, not recruiting --> Completed
- ||||| Enrollment change: SHaRCS: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (clinicaltrials.gov) - Jan 22, 2012
P3, N=907, Completed, Sponsor: NanoBio Corporation
Active, not recruiting --> Completed N=1600 --> 907
- ||||||| Trial completion: SHaRCS: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (clinicaltrials.gov) - Jan 22, 2012
P3, N=907, Completed, Sponsor: NanoBio Corporation
N=1600 --> 907 Recruiting --> Completed
- ||||| Enrollment change: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) (clinicaltrials.gov) - Jan 16, 2012
P3, N=847, Completed, Sponsor: NanoBio Corporation
Recruiting --> Completed N=1600 --> 847
- ||||||| Trial completion: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) (clinicaltrials.gov) - Jan 16, 2012
P3, N=847, Completed, Sponsor: NanoBio Corporation
N=1600 --> 847 Active, not recruiting --> Completed
- Trial termination: A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis (clinicaltrials.gov) - Jan 5, 2012
P2, N=11, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Completed --> Terminated; Terminated due to slow recruitment.
- Trial completion: Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis (clinicaltrials.gov) - Nov 16, 2011
P1, N=5, Completed, Sponsor: Southern California University of Health Sciences
Completed --> Terminated; Terminated due to slow recruitment. Recruiting --> Completed